Market Tracker

08/17 4:43pm ET

Allergan plc (NYSE:AGN)

224.77
Delayed Data
As of Aug 17
 -3.22 / -1.41%
Today’s Change
184.50
Today|||52-Week Range
256.80
+7.03%
Year-to-Date
AGN Regular Dividend: AGN began trading ex-dividend on 08/16/17. A $0.70 dividend will be paid to shareholders of record as of 08/18/17.
Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain
Aug 17 / TheStreet.com - Paid Partner Content
Black, Jewish Goldman Executive Sues Firm Over Discriminatory Practices
Aug 16 / TheStreet.com - Paid Partner Content
PayPal, Marriott International, Randgold Resources: 'Mad Money' Lightning Round
Aug 16 / TheStreet.com - Paid Partner Content
Pressing AGN Again
Aug 16 / TheStreet.com - Paid Partner Content
Valeant Pharmaceuticals: Cramer's Top Takeaways
Aug 16 / TheStreet.com - Paid Partner Content
Teva Is Cheap, Not Dead
Aug 16 / TheStreet.com - Paid Partner Content
The Market Is Not About Washington: Cramer's 'Mad Money' Recap (Wed 8/16/17)
Aug 16 / TheStreet.com - Paid Partner Content
Mid Afternoon Musings
Aug 15 / TheStreet.com - Paid Partner Content
Shire Files Marketing Application for Lifitegrast in Europe
Aug 16 / Zacks.com - Paid Partner Content
Are Amgen's New Drugs Doing Well Enough to Drive Sales?
Aug 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close227.99
Today’s open227.89
Day’s range224.11 - 229.10
Volume3,049,073
Average volume (3 months)2,165,774
Market cap$75.1B
Dividend yield1.25%
Data as of 4:01pm ET, 08/17/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+20.19%
Earnings growth (next 5 years)+15.23%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.06

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca-0.10-0.34%
ABTAbbott Laboratories-0.52-1.04%
LLYEli Lilly and Co-2.89-3.58%
NVONovo Nordisk-1.07-2.31%
Data as of 4:02pm ET, 08/17/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$4.17
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts